Cure My Disease

Don't miss your cure!

 Log in / Sign up

Austrian PBC registry aims to unlock secrets of rare liver disease

NCT ID NCT07598669

Knowledge-focused Sponsor: Medical University of Vienna Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a registry that will follow 500 people with primary biliary cholangitis (PBC) in Austria. Researchers will collect medical data and optional blood or liver samples to learn how the disease progresses and what complications arise. No new treatment is being tested; the goal is simply to gather information for future research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2040

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient with primary biliary cholangitis diagnosed and/or treated at one of the participating centers in Austria will be screened for inclusion/exclusion criteria.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \>18 years * Confirmed diagnosis of primary biliary cholangitis (at least two of the following three criteria must be fulfilled: persistent elevation of alkaline phosphatase above the upper limit of normal for at least 6 months; presence of antimitochondrial antibodies or PBC-specific antinuclear antibodies; characteristic histopathology) * Written informed consent for participation in the registry Exclusion Criteria: * Withdrawal of written informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Liver cirrhosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver portal hypertension primary biliary cholangitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Liver cirrhosis Portal hypertension Primary biliary cholangitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    11 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kepler Universitätsklinikum

    NOT_YET_RECRUITING

    Linz, Upper Austria, 4020, Austria

  • Klinik Landstraße

    NOT_YET_RECRUITING

    Vienna, State of Vienna, 1030, Austria

  • Klinik Ottakring

    NOT_YET_RECRUITING

    Vienna, State of Vienna, 1160, Austria

  • Klinikum Klagenfurt am Wörthersee

    NOT_YET_RECRUITING

    Klagenfurt, Carinthia, 9020, Austria

  • Klinikum Wels-Grieskirchen

    NOT_YET_RECRUITING

    Wels, Upper Austria, 4600, Austria

  • Medizinische Universität Graz

    NOT_YET_RECRUITING

    Graz, Styria, 8036, Austria

  • Medizinische Universität Innsbruck

    NOT_YET_RECRUITING

    Innsbruck, Tyrol, 6020, Austria

  • Medizinische Universität Wien

    RECRUITING

    Vienna, State of Vienna, 1090, Austria

  • Ordensklinikum Linz - Barmherzige Schwestern

    NOT_YET_RECRUITING

    Linz, Upper Austria, 4010, Austria

  • Universitätsklinikum Salzburg

    NOT_YET_RECRUITING

    Salzburg, State of Salzburg, 5020, Austria

  • Universitätsklinikum St. Pölten

    NOT_YET_RECRUITING

    Sankt Pölten, Lower Austria, 3100, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.